Homology model and docking studies on porcine β 2 adrenoceptor: Description of two binding sites

Journal of Molecular Modeling

Volumn 17, Issue 10, 2011, Pages 2525-2538

  Soriano Ursúa, Marvin A ^a   Correa Basurto, José ^a   Trujillo Ferrara, José G ^a   Kaumann, Alberto J ^b  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

2 adrenoceptor; 7TM receptors; Flex ligand docking; GPCR; Homology modeling; Pig

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; BINDING SITE; COMPARATIVE STUDY; COMPUTER MODEL; CRYSTAL STRUCTURE; EXPERIMENTAL PIG; HUMAN; IN VITRO STUDY; MOLECULAR DOCKING; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN STRUCTURE; STIMULATION;

ANIMALS; BINDING SITES; HUMANS; LIGANDS; MOLECULAR DYNAMICS SIMULATION; PROTEIN BINDING; PROTEIN CONFORMATION; RECEPTORS, ADRENERGIC, BETA-2; STRUCTURAL HOMOLOGY, PROTEIN; STRUCTURE-ACTIVITY RELATIONSHIP; SWINE;

SUIDAE; SUS;

EID: 80255138897     PISSN: 16102940     EISSN: 09485023     Source Type: Journal    
DOI: 10.1007/s00894-010-0915-1     Document Type: Article

References (72)

1. GP Anderson 2006 Current issues with beta2-adrenoceptor agonists: pharmacology and molecular and cellular mechanisms Clin Rev Allergy Immunol 31 119 130 10.1385/CRIAI:31:2:119 1:CAS:528:DC%2BD28XhtlCmurfF (Pubitemid 44804943)
2. Moody DE, Hancock DL, Anderson DB (2000) Phenetahnolamine repartitioning agents. In: D'Mello JPF (ed) Farma animal metabolism and nutrition. CAB International, Wallingford, pp 65-96
3. SG Rasmussen HJ Choi DM Rosenbaum TS Kobilka FS Thian PC Edwards M Burghammer VR Ratnala R Sanishvili RF Fischetti GF Schertler WI Weis BK Kobilka 2007 Crystal structure of the human beta2 adrenergic G-protein-coupled receptor Nature 450 383 387 10.1038/nature06325 1:CAS:528:DC%2BD2sXhtlajs77N (Pubitemid 350126755)
4. V Cherezov DM Rosenbaum MA Hanson SG Rasmussen FS Thian TS Kobilka HJ Choi P Kuhn WI Weis BK Kobilka RC Stevens 2007 High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor Science 318 1258 1265 10.1126/science.1150577 1:CAS:528:DC%2BD2sXhtlGmur7I (Pubitemid 350172884)
5. MA Hanson V Cherezov MT Griffith CB Roth VP Jaakola EY Chien J Velasquez P Kuhn RC Stevens 2008 A specific cholesterol binding site is established by the 2.8. A structure of the human beta2-adrenergic receptor Structure 16 897 905 10.1016/j.str.2008.05.001 1:CAS:528:DC%2BD1cXmvFertbo%3D (Pubitemid 351778384)
6. DM Rosenbaum V Cherezov MA Hanson SG Rasmussen FS Thian TS Kobilka HJ Choi XJ Yao WI Weis RC Stevens BK Kobilka 2007 7TM engineering yields high-resolution structural insights into beta2-adrenergic receptor function Science 318 1266 1273 10.1126/science.1150609 1:CAS:528:DC%2BD2sXhtlGmur7J (Pubitemid 350172885)
7. AK Shukla J Sun RJ Lefkowitz 2008 Crystallizing thinking about the β2-adrenergic receptor Mol Pharmacol 73 1333 1338 10.1124/mol.108.045849 1:CAS:528:DC%2BD1cXlsVWgtbo%3D (Pubitemid 351574821)
8. S Costanzi 2008 On the applicability of 7TM models to computer-aided drug discovery: a comparison between in silico and crystal structure of the β2-adrenergic receptor J Med Chem 51 2907 2914 10.1021/jm800044k 1:CAS:528:DC%2BD1cXlt1Ghu74%3D (Pubitemid 351706019)
9. S Topiol M Sabio 2008 Use of the X-ray structure of the Beta2-adrenergic receptor for drug discovery Bioorg Med Chem Lett 18 1598 1602 10.1016/j.bmcl.2008.01.063 1:CAS:528:DC%2BD1cXjt1Cktr0%3D (Pubitemid 351318251)
10. C De Graaf D Rognan 2008 Selective structure-based virtual screening for full and partial agonist of the β2 adrenergic receptor J Med Chem 51 4978 4985 10.1021/jm800710x
11. F Hausch 2008 Betablockers at work: the crystal structure of the beta2-adrenergic receptor Angew Chem Int Ed Engl 47 3314 3316 10.1002/anie.200705971 1:CAS:528:DC%2BD1cXmtlWksbk%3D
12. BJ Canning Y Chou 2008 Using guinea pigs in studies relevant to asthma and COPD Pulm Pharmacol Ther 21 702 720 10.1016/j.pupt.2008.01.004 1:CAS:528:DC%2BD1cXhtV2jtLfO
13. MA Soriano-Ursúa J Trujillo-Ferrara J Correa-Basurto 2009 Homology modeling and flex-ligand docking studies on the guinea pig β2 adrenoceptor: structural and experimental similarities/ differences with the human β2 J Mol Model 15 1203 1211 10.1007/s00894-009-0480-7
14. D Mustafi K Palczewski 2009 Topology of class A G protein-coupled receptors: insights gained from crystal structures of rhodopsins, adrenergic and adenosine receptors Mol Pharmacol 75 1 12 10.1124/mol.108.051938 1:CAS:528:DC%2BD1MXhvVOlsg%3D%3D
15. SN Fatakia S Costanzi CC Chow 2009 Computing highly correlated positions using mutual information and graph theory for G protein-coupled receptors PLoS ONE 4 e4681 10.1371/journal.pone.0004681
16. H Römpler C Stäubert D Thor A Schulz M Hofreiter TG Schöneberg 2007 Protein-coupled time travel: evolutionary aspects of 7TM research Mol Interv 7 17 25 10.1124/mi.7.1.5 (Pubitemid 46364321)
17. E Burgisser AA Hancock RJ Lefkowitz A Delean 1981 Anomalous equilibrium binding properties of high-affinity racemic radioligands Mol Pharmacol 19 205 216 1:STN:280:DyaL3M7pslaisg%3D%3D (Pubitemid 11004222)
18. W Liang S Mills 2001 Profile of ligand binding to the porcine β2 adrenergic receptor J Anim Sci 79 877 883 1:CAS:528:DC%2BD3MXjsVygu7Y%3D (Pubitemid 33696103)
19. MA Soriano-Ursúa JG Trujillo-Ferrara J Correa-Basurto 2010 Scope and difficulty in generating theoretical insights regarding ligand recognition and activation of the beta 2 adrenergic receptor J Med Chem 53 923 932 10.1021/jm900419a
20. W Liang CA Bidwell SK Williams SE Mills 1997 Rapid communication: molecular cloning of the porcine beta 2-adrenergic receptor gene J Anim Sci 75 2824 1:CAS:528:DyaK2sXmsVCntLY%3D
21. Y Zhang 2008 I-TASSER server for protein 3D structure prediction BMC Bioinform 9 40 10.1186/1471-2105-9-40 (Pubitemid 351267364)
22. Y Zhang 2007 Template-based modeling and free modeling by I-TASSER in CASP7 Proteins 8 108 117 10.1002/prot.21702 (Pubitemid 350210118)
23. S Wu J Skolnick Y Zhang 2007 Ab initio modeling of small proteins by iterative TASSER simulations BMC Biol 5 17 10.1186/1741-7007-5-17 (Pubitemid 46863697)
24. K Arnold L Bordoli J Kopp T Schwede 2006 The Swiss-model workspace: a web-based environment for protein structure homology modeling Bioinformatics 22 195 201 10.1093/bioinformatics/bti770 1:CAS:528:DC%2BD28XovVCltw%3D%3D (Pubitemid 43205406)
25. T Schwede J Kopp N Guex MC Peitsch 2003 Swiss-model: an automated protein homology-modeling server Nucleic Acids Res 31 3381 3385 10.1093/nar/gkg520 1:CAS:528:DC%2BD3sXltVWjsLg%3D (Pubitemid 37442164)
26. N Guex MC Peitsch 1997 Swiss-model and the Swiss-PdbViewer: an environment for comparative protein modeling Electrophoresis 18 2714 2723 10.1002/elps.1150181505 1:CAS:528:DyaK1cXhvFaks70%3D (Pubitemid 28059943)
27. 2: protein structure prediction server Nucleic Acids Res 34 W152 W157 10.1093/nar/gkl187 1:CAS:528:DC%2BD28Xps1yitbY%3D (Pubitemid 44529754)
28. BK Kobilka 2007 G protein coupled receptor structure and activation Biochim Biophys Acta 1768 794 807 10.1016/j.bbamem.2006.10.021 1:CAS:528:DC%2BD2sXjsVWhs7k%3D (Pubitemid 46452546)
29. Y Zhang J Skolnick 2004 Scoring function for automated assessment of protein structure template quality Proteins 57 702 710 10.1002/prot.20264 1:CAS:528:DC%2BD2cXhtVaqtLvI (Pubitemid 39626992)
30. SC Lovell IW Davis WB Arendall 3rd PI de Bakker JM Word MG Prisant JS Richardson DC Richardson 2003 Structure validation by Calpha geometry: phi, psi and Cbeta deviation Proteins 50 437 450 10.1002/prot.10286 1:CAS:528: DC%2BD3sXpvVKlsA%3D%3D (Pubitemid 36158457)
31. JC Phillips R Braun W Wang J Gumbart E Tajkhorshid E Villa C Chipot RD Skeel L Kale K Schulten 2005 Scalable molecular dynamics with NAMD J Comput Chem 26 1781 1802 10.1002/jcc.20289 1:CAS:528:DC%2BD2MXht1SlsbbJ (Pubitemid 43078511)
32. Y Zhang J Skolnick 2005 TM-align: a protein structure alignment algorithm based on the TM-score Nucleic Acids Res 33 2302 2309 10.1093/nar/gki524 1:CAS:528:DC%2BD2MXjsl2gsLY%3D (Pubitemid 41439897)
33. MA Soriano-Ursúa I Valencia-Hernández MG Arellano-Mendoza J Correa-Basurto JG Trujillo-Ferrara 2009 Synthesis, pharmacological and in silico evaluation of 1-(4-di-hydroxy-3, 5-dioxa-4-borabicyclo[4.4.0]deca-7, 9, 11-trien-9-yl)-2-(tert-butyl-amino) etha-nol, a compound designed to act as a β2 adrenoceptor agonist Eur J Med Chem 44 2840 2846 10.1016/j.ejmech.2008. 12.016
34. Frisch MJ, Trucks GW, Schlegel HB, et al. (1998) Gaussian 98, Version A.7. Gaussian Inc, Pittsburgh, PA
35. AT Laurie RM Jackson 2005 Q-SiteFinder: an energy-based method for the prediction of protein-ligand binding sites Bioinformatics 21 1908 1916 10.1093/bioinformatics/bti315 1:CAS:528:DC%2BD2MXjsl2ntL0%3D (Pubitemid 40668026)
36. GM Morris DS Goodsell RS Halliday R Huey E Hart RK Belew JA Olson 1998 Automated docking using a Lamarckian genetic algorithm and empirical binding free energy function J Comput Chem 19 1639 1662 10.1002/(SICI)1096- 987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B 1:CAS:528: DyaK1cXntFemur4%3D (Pubitemid 128590223)
37. PJ Goodford 1985 A computational procedure for determining energetically favorable binding sites on biologically important macromolecules J Med Chem 28 849 857 10.1021/jm00145a002 1:CAS:528:DyaL2MXktVeit7c%3D (Pubitemid 15012490)
38. W Humphrey A Dalke K Schulten 1996 VMD: visual molecular dynamics J Mol Graph 14 33 38 10.1016/0263-7855(96)00018-5 1:CAS:528:DyaK28Xis12nsrg%3D (Pubitemid 26152973)
39. V Katritch KA Reynolds V Cherezov MA Hanson CB Roth M Yeager R Abagyan 2009 Analysis of full and partial agonists binding to beta2-adrenergic receptor suggests a role of transmembrane helix V in agonist-specific conformational changes J Mol Recognit 22 307 318 10.1002/jmr.949 1:CAS:528:DC%2BD1MXnslGis7k%3D
40. 2 adrenoceptor model yield theoretical affinity values in function with experimental values for R-ligands, but not for S-antagonists J Mol Model 16 401 409 10.1007/s00894-009-0563-5
41. M Audet M Bouvier 2008 Insights into signaling from the beta2-adrenergic receptor structure Nat Chem Biol 4 397 403 10.1038/nchembio.97 1:CAS:528:DC%2BD1cXnt1ejtbo%3D (Pubitemid 351860553)
42. R Nygaard TM Frimurer B Holst MM Rosenkilde TW Schwartz 2009 Ligand binding and micro-switches in 7TM receptor structures Trends Pharmacol Sci 30 249 259 10.1016/j.tips.2009.02.006 1:CAS:528:DC%2BD1MXltlKktr8%3D
43. SA Green DA Rathz AJ Schuster SB Liggett 2001 The Ile164 beta(2)-adrenoceptor polymorphism alters salmeterol exosite binding and conventional agonist coupling to G(s) Eur J Pharmacol 421 141 147 10.1016/S0014-2999(01)01049-4 1:CAS:528:DC%2BD3MXksVGru7k%3D (Pubitemid 32539414)
44. SA Green G Cole M Jacinto M Innis SB Liggett 1993 A polymorphism of the human beta 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor J Biol Chem 268 23116 23121 1:CAS:528:DyaK3sXlslCgsL0%3D (Pubitemid 23328021)
45. 2 adrenoceptor binding site with catechol reveals differences in binding and activation by agonist and partial agonists J Biol Chem 280 22165 22171 10.1074/jbc.M502352200 1:CAS:528:DC%2BD2MXksl2hsbY%3D (Pubitemid 40827872)
46. MP Bokoch Y Zou SG Rasmussen CW Liu R Nygaard DM Rosenbaum JJ Fung HJ Choi FS Thian TS Kobilka JD Puglisi WI Weis L Pardo RS Prosser L Mueller BK Kobilka 2010 Ligand-specific regulation of the extracellular surface of a G-protein-coupled receptor Nature 463 108 112 10.1038/nature08650 1:CAS:528:DC%2BC3cXhvFeksQ%3D%3D
47. BK Kobilka X Deupi 2007 Conformational complexity of G-protein-coupled receptors Trends Pharmacol Sci 28 397 406 10.1016/j.tips.2007.06.003 1:CAS:528:DC%2BD2sXotlWltLk%3D (Pubitemid 47087966)
48. AJ Kaumann P Molenaar 2008 The low-affinity site of the beta1-adrenoceptor and its relevance to cardiovascular pharmacology Pharmacol Ther 118 303 336 10.1016/j.pharmthera.2008.03.009 1:CAS:528:DC%2BD1cXmvVyks70%3D
49. JF Heubach U Ravens AJ Kaumann 2004 Epinephrine activates both Gs and Gi pathways, but norepinephrine activates only the Gs pathway through human beta2-adrenoceptors overexpressed in mouse heart Mol Pharmacol 65 1313 1322 10.1124/mol.65.5.1313 1:CAS:528:DC%2BD2cXjsFKgt7s%3D (Pubitemid 38543502)
50. S Battacharya SE Hall H Li N Vaidehi 2008 Ligand stabilized conformational states of human beta 2 adrenergic receptor: insight into G protein coupled receptor activation Biophys J 94 2027 2042 10.1529/biophysj.107. 117648
51. LA Rubenstein RJ Zauhar RG Lanzara 2006 Molecular dynamics of a biophysical model for beta2-adrenergic and G protein-coupled receptor activation J Mol Graph Model 25 396 409 10.1016/j.jmgm.2006.02.008 1:CAS:528: DC%2BD28XhtFOhs7rN (Pubitemid 44667583)
52. RO Dror DH Arlow DW Borhani M∅ Jensen S Piana DE Shaw 2009 Identification of two distinct inactive conformations of the beta2-adrenergic receptor reconciles structural and biochemical observations Proc Natl Acad Sci USA 106 4689 4694 10.1073/pnas.0811065106 1:CAS:528:DC%2BD1MXktFOgt7k%3D
53. T Huber S Menon TP Sakmar 2009 Structural basis for ligand binding and specificity in adrenergic receptors: implications for 7TM-targeted drug discovery Biochemistry 47 11013 11023 10.1021/bi800891r
54. DM Rosenbaum SG Rasmussen BK Kobilka 2009 The structure and function of G-protein-coupled receptors Nature 459 356 363 10.1038/nature08144 1:CAS:528:DC%2BD1MXmtFKmsLg%3D
55. S Galandrin M Bouvier 2006 Distinct signaling profiles of β1 and β2 adrenergic receptor ligands towards adenylyl cyclase and mitogen-activated protein kinase reveals the pluridimensionality of efficacy Mol Pharmacol 70 1575 1584 10.1124/mol.106.026716 1:CAS:528:DC%2BD28XhtFygsbnJ
56. VP Jaakola MT Griffith MA Hanson V Cherezov EY Chien JR Lane AP Ijzerman RC Stevens 2008 The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist Science 322 1211 1217 10.1126/science.1164772 1:CAS:528:DC%2BD1cXhtlyqtbfN
57. P Chelikani V Hornak M Eilers PJ Reeves SO Smith UL RajBhandary HG Khorana 2007 Role of group-conserved residues in the helical core of beta2-adrenergic receptor Proc Natl Acad Sci USA 104 7027 7032 10.1073/pnas.0702024104 1:CAS:528:DC%2BD2sXls1KrtLw%3D (Pubitemid 47186003)
58. CM Fraser 1989 Site-directed mutagenesis of β-Adrenergic receptor J Biol Chem 264 9266 9270 1:CAS:528:DyaL1MXkvFantLY%3D
59. D Wacker G Fenalti MA Brown V Katritch R Abagyan V Cherezov RC Stevens 2010 Conserved binding mode of human β2 adrenergic receptor inverse agonists and antagonist revealed by X-ray crystallography J Am Chem Soc 132 11443 11445 10.1021/ja105108q 1:CAS:528:DC%2BC3cXpsV2mtLo%3D
60. JG Baker IP Hall SJ Hill 2002 Pharmacological characterization of CGP12177 at the human beta(2) adrenoceptor Br J Pharmacol 137 400 408 10.1038/sj.bjp.0704855 1:CAS:528:DC%2BD38Xns1Ciu7g%3D
61. VP Jaakola JR Lane JY Lin V Katritch AP Ijzerman RC Stevens 2010 Ligand binding and subtype selectivity of the human A(2A) adenosine receptor: identification and characterization of essential amino acid residues J Biol Chem 285 13032 13044 10.1074/jbc.M109.096974 1:CAS:528:DC%2BC3cXkvVGis7g%3D
62. C Hoffmann MR Leitz S Oberdorg-Maass MJ Lohse KN Klotz 2004 Comparative pharmacology of human β-adrenergic receptor subtypes - characterization of stably transfected in CHO cells Naunyn Schmiedebergs Arch Pharmacol 369 151 159 10.1007/s00210-003-0860-y 1:CAS:528:DC%2BD2cXhtVygtbc%3D (Pubitemid 38270770)
63. JG Baker 2005 The selectivity of β-adrenoceptor antagonists at the human β1-, β2- and β3-adrenoceptors Br J Pharmacol 144 317 322 10.1038/sj.bjp.0706048 1:CAS:528:DC%2BD2MXhtVGms70%3D (Pubitemid 40313677)
64. MN Sillence J Hooper GH Zhou Q Liu KJ Munn 2005 Characterization of porcine beta1- and beta2-adrenergic receptors in heart, skeletal muscle, and adipose tissue, and the identification of an atypical beta-adrenergic binding site J Anim Sci 83 2339 2348 1:CAS:528:DC%2BD2MXhtVKqsLvE
65. T Yamanishi CR Chapple K Yasuda K Yoshida R Chess-Williams 2003 The functional role of beta-adrenoceptor subtypes in mediating relaxation of pig urethral smooth muscle J Urol 170 2508 2511 10.1097/01.ju.0000085596.11247.78 (Pubitemid 37414045)
66. 2-adrenoceptors of newborn piglets: role of phosphodiesterases PDE3 and PDE4 Eur J Pharmacol 638 99 107 10.1016/j.ejphar.2010.04.013 1:CAS:528:DC%2BC3cXntVSns7k%3D
67. 2- adrenoceptor Cardiovasc Res 42 173 182 10.1016/S0008-6363(98)00262-4 1:STN:280:DyaK1MzmtlyltA%3D%3D (Pubitemid 29167082)
68. 2-adrenoceptor-mediated positive inotropic effects of adrenaline in human ventricular myocardium. Quantitative discrepancies with binding and adenylate cyclase stimulation Naunyn Schmiedebergs Arch Pharmacol 335 403 411 10.1007/BF00165555 1:CAS:528:DyaL2sXksFaltL4%3D (Pubitemid 17051888)
69. BF Buxton CR Jones P Molenaar RJ Summers 1987 Characterization and autoradiographic localization of beta-adrenoceptor subtypes in human cardiac tissues Br J Pharmacol 92 299 310 1:CAS:528:DyaL2sXls12gtb0%3D
70. 2-adrenoceptors of human heart. Differential antagonism of the positive inotropic effects and adenylate cyclase stimulation by (-)-noradrenaline and (-)-adrenaline Naunyn Schmiedebergs Arch Pharmacol 331 60 70 10.1007/BF00498852 1:CAS:528:DyaL28XhtVansrs%3D (Pubitemid 16191717)
71. 2-adrenoceptors of human atrium and ventricle to the effects of noradrenaline and adrenaline as assessed with (-)-atenolol Br J Pharmacol 95 55 66 1:CAS:528:DyaL1cXlsVeis7c%3D
72. JK Chong R Chess-Williams PT Peachell 2002 Pharmacological characterization of the β-adrenoceptor expressed by human mast cells Eur J Pharmacol 437 1 7 10.1016/S0014-2999(02)01263-3 1:CAS:528:DC%2BD38XhsFWnsL8%3D (Pubitemid 34178379)